West Pharmaceutical Services Inc
Open
SectorGezondheidszorg
328.35 0.12
Overzicht
Wijziging aandelenprijs
24u
Min
325.35
Max
329.03
Inkomsten | 6.7M 139M |
|---|---|
Verkoop | 40M 845M |
K/W Sectorgemiddelde | 42.017 49.052 |
EPS | 2.13 |
Dividendrendement | 0.27 |
Winstmarge | 16.428 |
Werknemers | 10,800 |
EBITDA | -36M 174M |
Aanbevelingen | Strong Buy |
|---|---|
12 Maanden Prognose | +13.44% upside |
Dividendrendement Sectorgemiddelde | 0.27% 2.36% |
|---|---|
Volgende Winsten | 23 jul 2026 |
Volgende dividenddatum | 5 aug 2026 |
Volgende Ex Dividend datum | 29 jul 2026 |
Marktkapitalisatie | 2.6B 23B |
|---|---|
Vorige openingsprijs | 328.23 |
Vorige sluitingsprijs | 328.35 |
Nieuwssentiment
By Acuity
50%
50%
146 / 342 Rangschikking in Healthcare
West Pharmaceutical Services Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.